AMERICAN SHARED HOSPITAL SERVICES (AMS) Operating Margin
- Operating margin · 12 months: Value -11.77%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -11.77% | Operating income / revenue. Period ending 2026-06-30. $-3.58M ÷ $30.41M × 100 ≈ -11.77% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -3.58M USD | Operating Income (Loss) |
| Revenue | 30.41M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | (m) | |
| Selling, general and administration | 7.48M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-3.58M | $30.41M | (m) | (m) | $7.48M | -11.77% |
| 2026-03-31 | $-3.21M | $29.05M | (m) | (m) | $7.18M | -11.06% |
| 2025-12-31 | $-3.59M | $28.08M | (m) | (m) | $7.08M | -12.78% |
| 2025-09-30 | $-4.02M | $29.42M | (m) | (m) | $6.80M | -13.65% |
| 2025-06-30 | $-4.56M | $29.25M | (m) | (m) | $7.19M | -15.60% |
| 2025-03-31 | $-4.02M | $29.24M | (m) | (m) | $7.34M | -13.75% |
| 2024-12-31 | $-2.81M | $28.34M | (m) | (m) | $7.41M | -9.90% |
| 2024-09-30 | $-568.00K | $24.97M | (m) | (m) | $7.46M | -2.27% |
| 2024-06-30 | $411.00K | $23.10M | (m) | (m) | $7.27M | 1.78% |
| 2024-03-31 | $87.00K | $21.62M | (m) | (m) | $7.36M | 0.40% |
| 2023-12-31 | $270.00K | $21.32M | (m) | (m) | $7.02M | 1.27% |
| 2023-09-30 | $453.00K | $20.66M | (m) | (m) | $6.68M | 2.19% |
| 2023-06-30 | $811.00K | $20.36M | (m) | (m) | $6.21M | 3.98% |
| 2023-03-31 | $1.93M | $19.82M | (m) | (m) | $5.37M | 9.73% |
| 2022-12-31 | $2.43M | $19.75M | (m) | (m) | $5.14M | 12.31% |
| 2022-09-30 | $2.56M | $19.40M | (m) | (m) | $4.96M | 13.22% |
| 2022-06-30 | $2.30M | $18.67M | (m) | (m) | $4.82M | 12.33% |
| 2022-03-31 | $1.86M | $18.11M | (m) | (m) | $4.77M | 10.28% |
| 2021-12-31 | $1.35M | $17.63M | (m) | (m) | $4.53M | 7.66% |
| 2021-09-30 | $-7.92M | $17.55M | (m) | (m) | $4.34M | -45.11% |
| 2021-06-30 | $-8.35M | $18.12M | (m) | (m) | $4.36M | -46.10% |
| 2021-03-31 | $-9.27M | $17.63M | (m) | (m) | $4.48M | -52.59% |
| 2020-12-31 | $-9.46M | $17.84M | (m) | (m) | $4.61M | -53.05% |
| 2020-09-30 | $-641.00K | $18.02M | (m) | (m) | $4.42M | -3.56% |
| 2020-06-30 | $56.00K | $18.65M | (m) | (m) | $4.34M | 0.30% |
| 2020-03-31 | $928.00K | $19.85M | (m) | (m) | $4.22M | 4.67% |
| 2019-12-31 | $1.54M | $20.61M | (m) | (m) | $4.06M | 7.48% |
| 2019-09-30 | $1.50M | $20.59M | (m) | (m) | $4.13M | 7.29% |
| 2019-06-30 | $1.24M | $19.76M | (m) | (m) | $4.11M | 6.27% |
| 2019-03-31 | $1.58M | $19.73M | (m) | (m) | $4.06M | 8.01% |
| 2018-12-31 | $1.86M | $19.71M | (m) | (m) | $3.99M | 9.44% |
| 2018-09-30 | $2.17M | (m) | (m) | (m) | $4.09M | (m) |
| 2018-06-30 | $2.43M | (m) | (m) | (m) | $4.06M | (m) |
| 2018-03-31 | $2.45M | (m) | (m) | (m) | $4.17M | (m) |
| 2017-12-31 | $2.41M | (m) | (m) | (m) | $4.32M | (m) |
| 2017-09-30 | $3.31M | (m) | (m) | (m) | $4.19M | (m) |
| 2017-06-30 | $3.77M | (m) | (m) | (m) | $4.17M | (m) |
| 2017-03-31 | $3.54M | (m) | (m) | (m) | $3.99M | (m) |
| 2016-12-31 | $3.29M | (m) | (m) | (m) | $3.80M | (m) |
| 2016-09-30 | $2.57M | (m) | (m) | (m) | $3.70M | (m) |
| 2016-06-30 | $1.99M | (m) | (m) | (m) | $3.61M | (m) |
| 2016-03-31 | $2.02M | (m) | (m) | (m) | $3.62M | (m) |
| 2015-12-31 | $1.98M | (m) | (m) | (m) | $3.50M | (m) |
| 2015-09-30 | $1.63M | (m) | (m) | (m) | $3.54M | (m) |
| 2015-06-30 | $1.59M | (m) | (m) | (m) | $3.57M | (m) |
| 2015-03-31 | $509.00K | (m) | (m) | (m) | $3.53M | (m) |
| 2014-12-31 | $-50.00K | (m) | (m) | (m) | $3.63M | (m) |
| 2014-09-30 | $-169.00K | (m) | (m) | (m) | $3.54M | (m) |
| 2014-06-30 | $-281.00K | (m) | (m) | (m) | $3.50M | (m) |
| 2014-03-31 | $605.00K | (m) | (m) | (m) | $3.71M | (m) |
| 2013-12-31 | $1.12M | (m) | (m) | (m) | $4.03M | (m) |
| 2013-09-30 | $914.00K | (m) | (m) | (m) | $4.23M | (m) |
| 2013-06-30 | $962.00K | (m) | (m) | (m) | $4.30M | (m) |
| 2013-03-31 | $903.00K | (m) | (m) | (m) | $4.26M | (m) |
| 2012-12-31 | $730.00K | (m) | (m) | (m) | $4.04M | (m) |
| 2012-09-30 | $999.00K | (m) | (m) | (m) | $3.93M | (m) |
| 2012-06-30 | $1.60M | (m) | (m) | (m) | $4.01M | (m) |
| 2012-03-31 | $1.60M | (m) | (m) | (m) | $3.94M | (m) |
| 2011-12-31 | $1.59M | (m) | (m) | (m) | $4.04M | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $865.00K | (m) | (m) | (m) | $4.24M | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $653.00K | (m) | (m) | (m) | $3.93M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |